We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

OptimizeRx Corp (OPRX) USD0.001

Sell:$8.52 Buy:$9.19 Change: $0.23 (2.47%)
Market closed |  Prices as at close on 22 April 2024 | Switch to live prices |
Sell:$8.52
Buy:$9.19
Change: $0.23 (2.47%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 April 2024 | Switch to live prices |
Sell:$8.52
Buy:$9.19
Change: $0.23 (2.47%)
Market closed |  Prices as at close on 22 April 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

OptimizeRx Corporation is a digital health technology company, which enables engagement between life sciences organizations, healthcare providers and patients. The Company's principal solutions include evidence-based physician engagement, point of care banner messaging, social network banner messaging, institutional account-based banner messaging, financial messaging, patient engagement and therapy initiation workflow. Its evidence-based physician engagement solution uses predictive analytics via machine learning methods applied to real-world data (RWD) to assist healthcare providers (HCPs). Its point of care banner messaging solution utilizes to deliver a variety of awareness and messaging within the clinical workflow, which can be tailored to meet the needs of each brand. Its Institutional Account-based Banner Messaging solution provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts.

Contact details

Address:
260 CHARLES STREET, SUITE 302
WALTHAM
02453
United States
Telephone:
+1 (248) 6516558
Website:
https://www.optimizerx.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
OPRX
ISIN:
US68401U2042
Market cap:
$169.47 million
Shares in issue:
18.18 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Stephen Silvestro
    President, Chief Commercial Officer
  • William Febbo
    Chief Executive Officer, Director
  • Edward Stelmakh
    Chief Financial Officer, Chief Operating Officer
  • Karina Castagna
    Senior Vice President - Access and Adherence
  • Todd Inman
    Chief Technology Officer
  • Marion Odence-Ford
    Chief Compliance Officer, General Counsel
  • Doug Besch
    Chief Product Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.